Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Culhane

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 25, 2019
The Impact of Stroma Admixture on Molecular Subtypes and Prognostic Gene Signatures in Serous Ovarian CancerMatthew Schwede, Levi Waldron, Samuel C Mok, et al.
British Journal of Cancer|April 30, 2009
Analysis of differential gene expression in colorectal cancer and stroma using fluorescence-activated cell sorting purificationM J Smith, A C Culhane, M Donovan, et al.
Journal of the National Cancer Institute|April 5, 2014
Comparative meta-analysis of prognostic gene signatures for late-stage ovarian cancerLevi Waldron, Benjamin Haibe-Kains, Aedín C Culhane, et al.
Trends in Genetics : TIG|August 26, 2018
Enter the Matrix: Factorization Uncovers Knowledge from OmicsGenevieve L Stein-O'Brien, Raman Arora, Aedin C Culhane, et al.
Cancer Discovery|November 8, 2015
MECP2 Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in MalignancyManish Neupane, Allison P Clark, Serena Landini, et al.
The Journal of Clinical Investigation|January 28, 2014
Taxonomy of breast cancer based on normal cell phenotype predicts outcomeSandro Santagata, Ankita Thakkar, Ayse Ergonul, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 10, 2013
Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancerChristian Bowman-Colin, Bing Xia, Samuel Bunting, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
Altered cytoplasmic-to-nuclear ratio of survivin is a prognostic indicator in breast cancerDonal J Brennan, Elton Rexhepaj, Sallyann L O'Brien, et al.
Cancer Research|August 30, 2020
Pleiotropic Mechanisms Drive Endocrine Resistance in the Three-Dimensional Bone MicroenvironmentEugen Dhimolea, Ricardo de Matos Simoes, Dhvanir Kansara, et al.
Briefings in Bioinformatics|October 15, 2015
Public data and open source tools for multi-assay genomic investigation of diseaseLavanya Kannan, Marcel Ramos, Angela Re, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 25, 2019
The Impact of Stroma Admixture on Molecular Subtypes and Prognostic Gene Signatures in Serous Ovarian CancerMatthew Schwede, Levi Waldron, Samuel C Mok, et al.
British Journal of Cancer|April 30, 2009
Analysis of differential gene expression in colorectal cancer and stroma using fluorescence-activated cell sorting purificationM J Smith, A C Culhane, M Donovan, et al.
Journal of the National Cancer Institute|April 5, 2014
Comparative meta-analysis of prognostic gene signatures for late-stage ovarian cancerLevi Waldron, Benjamin Haibe-Kains, Aedín C Culhane, et al.
Trends in Genetics : TIG|August 26, 2018
Enter the Matrix: Factorization Uncovers Knowledge from OmicsGenevieve L Stein-O'Brien, Raman Arora, Aedin C Culhane, et al.
Cancer Discovery|November 8, 2015
MECP2 Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in MalignancyManish Neupane, Allison P Clark, Serena Landini, et al.
The Journal of Clinical Investigation|January 28, 2014
Taxonomy of breast cancer based on normal cell phenotype predicts outcomeSandro Santagata, Ankita Thakkar, Ayse Ergonul, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 10, 2013
Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancerChristian Bowman-Colin, Bing Xia, Samuel Bunting, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
Altered cytoplasmic-to-nuclear ratio of survivin is a prognostic indicator in breast cancerDonal J Brennan, Elton Rexhepaj, Sallyann L O'Brien, et al.
Cancer Research|August 30, 2020
Pleiotropic Mechanisms Drive Endocrine Resistance in the Three-Dimensional Bone MicroenvironmentEugen Dhimolea, Ricardo de Matos Simoes, Dhvanir Kansara, et al.
Briefings in Bioinformatics|October 15, 2015
Public data and open source tools for multi-assay genomic investigation of diseaseLavanya Kannan, Marcel Ramos, Angela Re, et al.
Pageof 9